Philips Introduces the New Spectral Computed Tomography 7500 System

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its newest solution for precision diagnosis with the global introduction of its spectral detector-based Spectral Computed Tomography (CT) 7500. This latest intelligent system delivers high quality spectral images for every patient on every scan 100% of the time to help improve disease characterization, and reduce rescans and follow-ups, all at the same dose levels as conventional scans. The time-saving spectral workflow is fully integrated, enabling the technologist to get the patient on and off the table quickly - spectral chest scans and head scans take less than one second, and a full upper body spectral scan can be completed in less than two seconds - while still delivering high quality imaging that allows the physician to rapidly deliver a confident diagnosis and effective treatment plan for each patient.

Human and financial cost of misdiagnosis

Missed and delayed diagnoses contribute to roughly 10% of patient deaths annually [1], while an estimated 10-20% of all medical diagnoses are inaccurate [2]. The financial costs resulting from unnecessary, suboptimal and repeat imaging costs as much as $12 Billion USD annually [3]. The new Spectral CT 7500 was designed for first-time-right diagnosis and has demonstrated a 34% reduction in time to diagnosis, a 25% reduction in repeat scans and a 30% reduction in follow-up scans [4].

"With such great human and financial costs due to misdiagnosis, Spectral CT 7500 sets a new standard of care where image quality, dose and workflow come together to deliver valuable clinical insights. This latest intelligent system helps to bring clarity to defining moments in healthcare by delivering on certainty, simplicity and reliability in every clinical area from cardiac care, to emergency radiology, diagnostic oncology, intervention and radiation oncology," said Kees Wesdorp, Chief Business Leader of Precision Diagnosis at Philips. "Our detector-based spectral technology ensures spectral data is always available and is seamlessly integrated into current workflows, meaning scans are fast, and clinicians are able to send patients the right treatment pathway with a more confident diagnosis."

Spectral CT has demonstrated a higher sensitivity in detecting malignant findings and has improved readings of incidental findings [5] [6]. With Philips spectral detector CT, photons add more value by helping salvage sub-optimal injection scans without the need to re-scan the patients, shortening the time to diagnosis.

"We rely on CT scans to provide us valuable insights. But conventional CT scanners are limited and can only show us where things are located - like lesions, cysts, bleeds, fractures and more. Philips spectral detector-based systems help to characterize what the finding is, not just where it is, providing us greater confidence in diagnoses," said Dr. Finn Rasmussen, Associate Professor, Consultant Radiologist, MD, DMSc at Aarhus University. “We have seen significant reductions in rescans and follow-ups by adopting spectral into our workflow for faster and more accurate diagnosis [7].”

Expanded patient populations and optimized workflows

Spectral CT 7500 expands on Philips proven spectral-detector benefits to now include additional patient populations that were not previously served. The spectral insights are available for all patients, from pediatric to bariatric, and for any clinical indication, including challenging cardiac scans with high and irregular heart rates, without compromising image quality, dose or workflow. The spectral workflow enables radiologists to optimize reading with rich spectral results and AI-based smart tools available in any reading environment with Spectral Magic Glass on PACS.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 77,000 employees with sales and services in more than 100 countries.

1. https://pubmed.ncbi.nlm.nih.gov/23011708/
2. https://www.coverys.com/About-Us/Foundation/Grants-For-Improving-Diagnostic-Accuracy
3. https://reactiondata.com/wp-content/uploads/2015/02/peer60:unnecessaryimaging.pdf
4. Analysis by CARTI Cancer Center in Little Rock Arkansas and University Hospitals of Cleveland - Results from case studies are not predictive of results in other cases. Results in other cases may vary.
5. Analysis by Aarhus University Hospital Aarhus, Denmark. Results from case studies are not predictive of results in other cases. Results in other cases may vary.
6. Analysis by University Hospital Cleveland, USA. Results from case studies are not predictive of results in other cases. Results in other cases may vary.
7. Results from case studies are not predictive of results in other cases. Results in other cases may vary.

Most Popular Now

AI Predicts Lung Cancer Risk

An artificial intelligence (AI) program accurately predicts the risk that lung nodules detected on screening CT will become cancerous, according to a study published in the journal Radiology. Lung cancer is...

EU Health Policy Platform Calls for Prop…

The European Commission is inviting public health stakeholders to submit initiatives for anew cycle of Thematic Networks under the EU Health Policy Platform. The purpose of a Thematic Network is...

What Next for Social Care?

Highland Marketing's advisory board welcomed Jane Brightman, social care lead at Institute of Health and Social Care Management, to discuss the sector and its technology needs. A lot of hope...

Philips Introduces the New Spectral Comp…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its newest solution for precision diagnosis with the global introduction of its spectral detector-based Spectral Computed...

Web-Based System Developed to Give Care …

Black Country Pathology Services has worked with CliniSys to create the ICE Portal, a web-based application that makes it easy for care homes, or other community care settings, to be...

Grand Challenge Research Harnesses AI to…

Breast cancer has recently overtaken lung cancer to become the most common cancer globally, according to the World Health Organization. Advancing the fight against breast cancer, the BreastPathQ Challenge was...

UCSF Improves Fetal Heart Defect Detecti…

UC San Francisco researchers have found a way to double doctors' accuracy in detecting the vast majority of complex fetal heart defects in utero - when interventions could either correct...

EU4Health Programme: Regulation (EU) 202…

The Programme should be a means of promoting actions in areas where there is a Union added value that can be demonstrated. Such actions should include, inter alia, strengthening...

MEDICA 2021 + COMPAMED 2021: Medical Tec…

15 - 18 November 2021, Düsseldorf, Germany. The date for the globally leading live platforms for the medical technology industry remains a fixed feature in everybody's calendar this year too. The...

New AI Technology Protects Privacy

Digital medicine is opening up entirely new possibilities. For example, it can detect tumors at an early stage. But the effectiveness of new AI algorithms depends on the quantity and...

GP use of Tech Helps Prevent Prescribing…

Academic analysis shows primary care prescribers have been preventing adverse drug reactions, harm and hospital admissions through safer prescribing, after using prescribing tech. The company behind the system also reveals...